Deletion analysis of the Clostridium perfringens enterotoxin

Infection and Immunity

Volumn 65, Issue 3, 1997, Pages 1014-1022

  Kokai Kun, John F ^a   McClane, Bruce A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM TOXIN;

ARTICLE; CLOSTRIDIUM PERFRINGENS; COMPLEX FORMATION; CYTOTOXICITY; GENETIC ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0031019653     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.3.1014-1022.1997     Document Type: Article

References (32)

1. Czeczulin, J. R., R. E. Collie, and B. A. McClane. 1996. Regulated expression of the Clostridium perfringens enterotoxin in naturally cpe-negative type A, B, and C isolates of C perfringens. Infect. Immun, 64:3301-3309.
2. Czeczulin, J. R., P. C. Hanna, and B. A. McClane. 1993. Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli. Infect. Immun. 61:3429-3439.
3. Granum, P. E., and M. Richardson. 1991. Chymotrypsin treatment increases the activity of Clostridium perfringens enterotoxin. Toxicon 29:445-453.
4. Granum, P. E., J. R. Whitaker, and R. Skjelkvale. 1981. Trypsin activation of enterotoxin from Clostridium perfringens type A. Biochim. Biophys, Acta 668:325-332.
5. Hanna, P. C., and B. A. McClane. 1991. A recombinant C-terminal toxin fragment provides evidence that membrane insertion is important for Clostridium perfringens enterotoxin cytotoxicity. Mol. Microbiol. 5:225-230.
6. Hanna, P. C., T. A. Mietzner, G. K. Schoolnik, and B. A. McClane. 1991. Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region. J. Biol. Chem. 266:11037-11043.
7. Hanna, P. C., E. U. Wieckowski, T. A. Mietzner, and B. A. McClane. 1992. Mapping functional regions of Clostridium perfringens type A enterotoxin. Infect. Immun. 60:2110-2114.
8. Hanna, P. C., A. P. Wnek, and B. McClane. 1989. Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity. J. Bacteriol. 171:6815-6820.
9. Hauser, D., M. W. Eklund, P. Boquet, and M. R. Popoff. 1994. Organization of the botulinum neurotoxin C1 gene and its non-toxic protein genes in Clostridium botulinum C 468. Mol. Gen. Genet. 243:631-640.
10. Horiguchi, Y., T. Akai, and G. Sakaguchi. 1987. Isolation and function of a Clostridium perfringens enterotoxin fragment. Infect. Immun. 55:2912-2915.
11. Hulkower, K. I., A. P. Wnek, and B. A. McClane. 1989. Evidence that alterations in small molecule permeability are involved in the Clostridium perfringens type-A enieroioxin-induced inhibition of macromolecular synthesis in Vero cells. J. Cell. Physiol. 140:408-504.
12. Kokai-Kun, J. F., and B. A. McClane. 1996. Evidence that a region(s) of the Clostrdium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or larjie complex. Infect, Immun. 64:1020-1025.
13. Kokai-Kun, J. F., J. G. Songer, J. R. Czeczulin, F. Chen, and B. A. MeClane. 1994. Comparison of Western immunoblnts and gene detection assays for identification of potentially enterotoxigenie isolates of Clostridium perfringens. J. Clin. Microbiol. 32:2533-2539.
14. Lowry, O., H., N. J. Rosehrough, A. L. Fair, und R. J. Randall. 1951. Protein measurement with the Polin phenol reagent. J. Biol. Chem. 193:265-275.
15. Matsuda, M., K. Ozutsumi, H. Iwashi, and N. Suuimoto, 1986. Primary action of Clostridium perfringens type A enterotoxin on HeLa and Vero cells in the absence of extracellular calcium: rapid and characteristic changes in membrane permeability, Riochem, Biophys. Res. Commun. 141:704-710.
16. McClane, B. A. 1984, Osmotic stabilizers differentially inhibit permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin. Biochim. Biophys. Acta 777:99-106.
17. McClane, B. A. 1986. Clostridium perfrigenes type A enterotoxin. p. 53-62. In H. Bergmeyer (ed.), Methods of enzymatic analysis, vol. XI. Antigens and antibodies, Verlag Chemie, Weinheim, Germany.
18. McClane, B. A. 1902. Clostridium perfringens enterotoxin: structure, action and detection. J. Food Saf. 12:237-252.
19. McClane, B. A. 1994. Clostridium perfringens enterotoxin acts by producing small molecule permeability alterations in plasma membranes. Toxicology 87:43-67.
20. McClane, B. A., P. C. Hanna, and A. P. Wnek. 1988. Clostridium perfringens type A enteroloxin. Microb. Pathog. 4:317-323.
21. McClane, B. A., and J. L. McDonel. 1980. Characterization of membrane permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin. Biochim. Biophys. Acta 600:974-985.
22. McClane, B. A., and J. L. McDonel. 1981. Protective effects of osmotic stabilizers on morphological and permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin. Biochim. Biophys. Acta 641:401-409.
23. McClane, B. A., and A. P. Wnek. 1990. Studies of Clostridium perfringens enterotoxin action at different temperatures demonstrate a correlation between complex formation and cytoioxicity. Infect. Immun. 58:3109-3115.
24. McClane, B. A., A. P. Wnek, K. I. Hulkower, and P. C. Hanna. 1988. Divalent cation involvement in the action of Clostridium perfringens type A enterotoxin. J. Biol. Chem. 263:2423-2435.
25. 125I-enterotoxin to rabbit intestinal cells. Biochemistry 21:4801-4807.
26. McDonel, J. L., and B. A. McClane. 1979. Binding vs, biological activity of Clostridium perfringens enterotoxin in Vero cells. Biochem. Biophys. Res. Commun. 87:497-504.
27. McDonel, J. L., and B. A. McClane. 1988. Production, purification and assay of Clostridium perfringens enterotoxin. Methods Enzymol. 165:94-103.
28. Sambrook, J. E., E. F. Fritsch, and T. Maniatls. 1989. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
29. Sigrist, H., P. Ronner, and G. Semenza. 1975, A Hydrophobic form of the small-intestinal sucrase-isomaltase complex. Biochim. Biophys. Acta 406: 433-146.
30. Wieckowski, E. U., A. P. Wnek, and B. A. McClane. 1994. Evidence that an ∼50kDa mammalian plasma membrane protein with receptor-like propertics mediates the amphiphilicity of specifically-bound Closeridium perfringens enterotoxin. J. Biol. Chem. 269:10838-10848.
31. Wnek, A. P., and B. A. McClane. 1989. Preliminary evidence that Clostridium perfringens type A enterotoxin is present in a 160,000-M,. complex in mammalian membranes. Infect. Immun. 57:574-581,
32. Wnek, A. P., R. Strouse, and B. A. McClane. 1985, Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin. Infect. Immun. 50:442-448.